Supporting these findings, a recent study using an orthotopic murine pancreatic ductal adenocarcinoma (PDAC) tumor model demonstrates that the GLUT1 depletion in TAMs via lysozyme M‐cre (LysMcre) improved natural killer and CD8+ T cell activity and inhibited tumor progression. This evidence concerns the gene SLC2A1 and neoplasm.